PYRAMID-ANALYTICS
31.3.2022 16:37:11 CEST | Business Wire | Press release
Experts from Delaware and Pyramid Analytics will explore why and how Decision Intelligence – what’s next in analytics and business intelligence (ABI) – should be introduced into enterprise platforms at the UKISUG Analytics Symposium , an annual event for the independent UK & Ireland SAP User Group being held on 5 April, 2022 at The Vox Conference Centre, Birmingham. The conference offers the opportunity for networking and collaboration among peers specialising in SAP Analytics Cloud, data preparation, platform & database and digital transformation.
UKISUG Analytics Symposium is free to attend. Register here .
Key Points:
- Delaware’s Analytics Lead and Pyramid’s Director of Product Management will discuss Decision Intelligence and how to introduce it into an SAP business and technology ecosystem.
- Delaware implements the Pyramid Decision Intelligence Platform across the UK & Ireland to help organisations leverage the full value of data by providing AI-powered analytics to all decision-makers.
- Both companies have partnerships with SAP and expertise in the SAP technology ecosystem .
- Pyramid Analytics is an official member of the SAP® PartnerEdge® open ecosystem. Pyramid Platform is certified by SAP Certified for SAP BW/4HANA, SAP HANA, and SAP NetWeaver.
Attendees, Mark Your Diaries
Chris Houlder, Analytics Lead at Delaware, and Ian MacDonald, Director of Product Management with Pyramid, will discuss how enterprises running on SAP can best understand their data and how to react to fast-changing conditions, and address the challenges of adopting a holistic platform that works directly on both SAP BW and SAP HANA. The session will also include a demo of the Pyramid Analytics Decision Intelligence platform and how to get more value from these SAP investments. The session begins at 10 a.m. GMT.
Partnership Brings Decision Intelligence to Enterprises Across the UKI
Pyramid Analytics and global IT services company Delaware have a partnership agreement through which the companies jointly sell and implement the Pyramid Platform for decision intelligence and provide consulting services. The partnership puts the Pyramid Platform for decision intelligence into the hands of more than 3,000 Delaware consultants. The Pyramid Platform uniquely combines Data Preparation, Business Analytics, and Data Science in a single Analytics and Business Intelligence (ABI) environment. Leading technology analysts BARC, Dresner Advisory Services, and Gartner rank Pyramid first in critical ABI capabilities .
Pyramid and Delaware have strong partnerships with SAP, the world’s largest provider of Enterprise Application Software. Delaware and Pyramid Analytics jointly deliver solutions enabling customers to integrate sophisticated SAP data sets and non-SAP sources, from a wide range of on-premises and cloud-based data sources, without moving or ingesting the data, through a single decision intelligence platform.
Many of Delaware’s clients have complex landscapes and face challenges pulling together accurate and coherent reporting. Pyramid enables all users, from data scientists to non-technical business users, to maximise their investments in SAP providing for the fastest, direct querying and analytics on BW, BEx, HANA, CDS and IQ, while maintaining the investment in business logic and security designed into SAP — all within a complete point and click, no-code, governed self-service analytics environment.
Quotes
Ian Macdonald, Director of Product Management, Pyramid Analytics : “Business success in today’s dynamic markets requires organizations to react to trends and opportunities in real time with accuracy, speed and scale. Data drives better decisions. However, due to legacy tool limitations, integration issues and data management challenges, many SAP customers struggle to expose all the necessary data to deliver modern self-service analytic capabilities. Pyramid Decision Intelligence Platform allows business users to get more value out of their existing SAP BW and SAP HANA investments, delivering best-in-class functionality and performance that preserves the security and governance inherent in the SAP platform.”
Complete, Unified Decision Intelligence
Pyramid’s Decision Intelligence Platform unifies Data Preparation, Business Analytics, and Data Science on a single, integrated platform. This eliminates the need to use multiple disparate tools and the associated license cost and management complexity. Lower Total Cost of Ownership (TCO), rapid rollout, quicker and direct access to all available data, and industry-leading user adoption means faster time to value. Pyramid’s Decision Intelligence Platform can be deployed on-premises, into a private or public cloud, embedded into other apps or delivered through Managed Services Providers (MSP).
About Delaware
Delaware is a fast-growing, global company that delivers advanced solutions and services to organisations striving for a sustainable, competitive advantage. Delaware guides its customers through their business transformation, applying the ecosystems of its main business partners, SAP and Microsoft. Delaware continues to service its customers afterwards, assuring continuity and continuous improvement. Delaware has over 3000 professionals in 24 offices around the world. For more information, please visit www.delaware.co.uk .
About Pyramid Analytics
Pyramid is what’s next in analytics. Our unified decision intelligence platform delivers insights for everyone to make faster, more informed decisions. It provides direct access to any data, enables governed self-service for any person, and serves any analytics need in a no-code environment. The Pyramid Decision Intelligence Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. The Pyramid Platform enables a strategic, organization-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Schedule a demo .
Pyramid Analytics is incorporated in Amsterdam and has regional headquarters in global innovation and business centers, including London, New York City, and Tel-Aviv. Our team lives worldwide because geography should not be a barrier to talent and opportunity. Investors include Jerusalem Venture Partners (JVP), Sequoia Capital and Viola Growth. Learn more at Pyramid Analytics .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220331005705/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing23.3.2026 07:00:00 CET | Press release
The United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Contour* for the correction of temple hollowing, expanding its use beyond cheek augmentation and midface contour deficiencies to support overall facial balance and harmony1-3 The approval is based on clinical data showing Restylane Contour, part of Galderma’s versatile portfolio of hyaluronic acid injectables, delivers natural-looking results lasting for up to 18 months and high patient satisfaction1,2 This follows the recent U.S. FDA approval for Restylane Lyft™ for the enhancement of the chin profile and the debut of the ‘Wake Up to Restylane’ campaign in the U.S., highlighting Galderma’s commitment to continuing to evolve this versatile portfolio to meet emerging and diverse needs, including the desire for effortless, ‘wake‑up‑ready’ beauty4 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hol
Paving the Way for Real‑Time Earth Observation: Space Compass and SWISSto12 Sign Contract for First Commercial GEO Optical Data Relay Satellite23.3.2026 05:00:00 CET | Press release
Space Compass Corporation (“Space Compass”) and SWISSto12 SA (“SWISSto12”) announced today that they have executed a procurement contract for the first GEO optical data relay satellite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260320584108/en/ (From Left to Right): Julie Pignon, Legal Counsel, SWISSto12; 倉田 るり子 (Ruriko Kurata), Legal Counsel, Space Compass; 小松 大実 (Hiromi Komatsu), Co-CEO, Space Compass; 田中 良太 (Ryota Tanaka), Engineering Director, Space Compass; Emile de Rijk, CEO, SWISSto12; Fredrik Gustavsson, Chief Financial and Strategy Officer, SWISSto12. This agreement represents a major milestone toward the realization of Space Compass’s optical data relay service. With high-speed, high-capacity optical data relay service, Space Compass aims to transform Earth Observation from just a tracking record into a real-time decision-making tool. For SWISSto12, the contract represents further validation of the company’s a
Andersen Consulting styrker sit cybersikkerhedstilbud gennem samarbejde med Trillium Information Security Systems21.3.2026 02:16:00 CET | Pressemeddelelse
Andersen Consulting udbygger sine kompetencer inden for teknologi og risikostyring gennem en samarbejdsaftale med Trillium Information Security Systems (TISS), et cybersikkerhedsfirma. Med en tilstedeværelse i Canada og Pakistan leverer TISS omfattende cybersikkerhedsløsninger til organisationer inden for finans, telekommunikation og den offentlige sektor. Virksomhedens team tilbyder et bredt udvalg af ydelser, herunder sikkerhedsvurderinger, managed security operations, red team-tjenester, digital efterforskning og hændelsesrespons samt GRC-rådgivning. Med næsten to årtiers erfaring leverer TISS adaptive, efterretningsdrevne forsvarsmekanismer, der hjælper kunder med at forudse og reagere på cybertrusler, der er i konstant udvikling. "Hos TISS arbejder vi på at skabe et mere sikkert digitalt miljø ved at give organisationer mulighed for at operere sikkert og med selvtillid," udtalte Mahir Mohsin Sheikh, administrerende direktør for TISS. "Vores samarbejde med Andersen Consulting giver
Andersen Consulting udvider sin teknologiplatform i Frankrig20.3.2026 17:28:00 CET | Pressemeddelelse
Andersen Consulting udvider sit udbud inden for digital transformation med en samarbejdsaftale med Teolia Consulting, et fransk firma, der specialiserer sig i projekt- og produktstyring, cloud-platformsudvikling, datatransformation samt implementering og brug af Atlassian-pakken. Teolia Consulting blev grundlagt i 2014 og hjælper organisationer med at opnå digital performance, fra agile metoder til løsninger, der reducerer lanceringstiden. Virksomhedens ekspertise består i at levere integrerede strategier, der bringer teknologi og organisatorisk forandring i overensstemmelse. Virksomheden arbejder på tværs af brancher, herunder inden for bank- og finanssektoren, forsikring, mode og detailhandel, og hjælper kunder med at få større robusthed og accelerere deres digitale modenhed. "Hos Teolia Consulting mener vi, at ægte transformation opstår, når teknologi og mennesker udvikler sig sammen," sagde Lucienne Jacquet, der er administrerende partner i Teolia. "Ved at samarbejde med Andersen C
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting20.3.2026 15:00:00 CET | Press release
- New, late-breaking 54-week data for povorcitinib in hidradenitis suppurativa (STOP-HS1 & STOP-HS2) to be highlighted - Featured abstracts for ruxolitinib cream (Opzelura®) and povorcitinib include multiple ePosters in atopic dermatitis, hidradenitis suppurativa and vitiligo Incyte (Nasdaq:INCY) today announced that data from key programs in its Inflammation and Autoimmunity (IAI) franchise will be presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting, to be held March 27 – 31, 2026, in Denver. “At AAD 2026, we are presenting late‑breaking 54-week results from the Phase 3 STOP‑HS program evaluating povorcitinib in hidradenitis suppurativa (HS),” said Jim Lee, M.D., Ph.D., Group Vice President, Inflammation and Autoimmunity, Incyte. “These data provide longer term evidence of the safety and efficacy of povorcitinib in HS patients and further strengthen the significant growth potential of our Inflammation and Autoimmunity franchise.” Details on key data presentation
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom